Last reviewed · How we verify

Oral N-Acetyl Cystein — Competitive Intelligence Brief

Oral N-Acetyl Cystein (Oral N-Acetyl Cystein) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: antioxidant and mucolytic. Area: Respiratory.

phase 3 antioxidant and mucolytic Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Oral N-Acetyl Cystein (Oral N-Acetyl Cystein) — Imam Khomeini Hospital. N-Acetyl Cysteine acts as an antioxidant and mucolytic agent by replenishing intracellular glutathione levels and breaking disulfide bonds in mucus.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oral N-Acetyl Cystein TARGET Oral N-Acetyl Cystein Imam Khomeini Hospital phase 3 antioxidant and mucolytic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (antioxidant and mucolytic class)

  1. Imam Khomeini Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral N-Acetyl Cystein — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-n-acetyl-cystein. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: